Substance-Related Disorders

66 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Mental Disorders

Narrower: Alcohol-Related Disorders 25, Alcoholism 22, Cocaine-Related Disorders 5, Hepatitis, Alcoholic 1, Liver Diseases, Alcoholic 2, Marijuana Abuse 3, Marijuana Use 1, Opioid-Related Disorders 19, Tobacco Use Disorder 6

Treatments and conditions

Substance-Related Disorders
Treatment and conditionWhere it standsTrials
Acceptance and Commitment Therapy + Ketamine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baclofen for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Baclofen for liver diseases, alcoholicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Brenipatide for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Brenipatide for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brief Negotiation Interview for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brief Negotiation Interview + Naltrexone + Gabapentin for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cabotegravir for substance-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cannabidiol for marijuana abusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Cannabidiol + Dronabinol for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet + Naproxen 500 Mg + Opioids for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CI-581a for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Combined LAI Treatment: Cabenuva and Sublocade for opioid-related disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Contingency management for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Quitting using Medication for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Counseling + Switching to E-Cigarette for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Daridorexant for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
DBS of the NAc for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Simulator for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diamorphine hydrochloride anhydrous for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dronabinol for marijuana abusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DynamiCare Health for opioid-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
E-Cigarette 7.2 mg nicotine for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
electronic cigarette for tobacco use disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Endd (njoy) for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Faecal microbiota transplantation for hepatitis, alcoholicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High THC Cannabis for marijuana abuseTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ibogaine hydrochloride for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Increasing control over stimulant use and physical health through incentivized rehabilitation for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketamine Hydrochloride for alcoholismPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
kudzu extract, puerarin for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lifus for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-intensity focused ultrasound for cocaine-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-intensity focused ultrasound for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-Intensity Focused Ultrasound + Low-Intensity Focused Ultrasound - sham for opioid-related disordersTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Matched Placebo (oral gummy) + Δ9-Tetrahydrocannabivarin (oral gummy) for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Matching Intramuscular Placebo + IBOGAINE HYDROCHLORIDE for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MDMA Assisted Therapy for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Midomafetamine for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Midomafetamine for substance-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mindset for alcohol-related disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Next Generation Dome Helmet (NGDH) for substance-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Pemvidutide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Nimodipine for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Prolonged exposure therapy + MIDOMAFETAMINE for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)8
Psilocybin for cocaine-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psychotherapy + Medication for opioid use disorder for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Questionnaires for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
real-time fMRI neurofeedback training for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
real-time fMRI neurofeedback training + Ketamine for cocaine-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) for alcoholismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters) for opioid-related disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
STAM 1100mAh CE4 eGo Clearomizer for tobacco use disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Standardized kudzu for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Treatment with Ketone Supplement for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treatment with Placebo for opioid-related disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Varenicline for marijuana usePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Varenicline for tobacco use disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zonisamide for alcoholismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.